Cooper Investors Pty LTD Royalty Pharma PLC Transaction History
Cooper Investors Pty LTD
- $616 Billion
- Q1 2025
A detailed history of Cooper Investors Pty LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cooper Investors Pty LTD holds 416,536 shares of RPRX stock, worth $14.7 Million. This represents 2.11% of its overall portfolio holdings.
Number of Shares
416,536
Previous 416,536
-0.0%
Holding current value
$14.7 Million
Previous $10.6 Billion
22.03%
% of portfolio
2.11%
Previous 1.67%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.45 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.29 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$812 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$473 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$429 Million0.52% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...